No Data
No Data
Aipon Healthcare (300753.SZ) 2023 annual equity distribution: 0.65 yuan for every 10 shares, share registration on May 31
Aipon Healthcare (300753.SZ) issued an announcement. The company's 2023 equity distribution plan is: Based on the company's total...
Aipeng Healthcare (300753.SZ) increased their holdings by 558,600 shares in total after half of the increase period
Aipeng Healthcare (300753.SZ) announced that some of the company's directors and senior management plans to increase their share holdings are over half of the time...
Aipon Healthcare (300753.SZ): Net profit of 1,356.95 million yuan in the first quarter increased 11.63% year-on-year
On April 25, Ge Longhui | Aipeng Healthcare (300753.SZ) released its report for the first quarter of 2024. The operating income for the reporting period was 87.752.96 million yuan, down 6.71% year on year; net profit attributable to shareholders of listed companies was 1,356.95 million yuan, up 11.63% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 1,7202 million yuan, an increase of 76.41% year on year; basic earnings per share were 0.0108 yuan.
The Recent CN¥416m Market Cap Decrease Is Likely to Have Disappointed Insiders Invested in Jiangsu Apon Medical Technology Co., Ltd. (SZSE:300753)
Key Insights Jiangsu Apon Medical Technology's significant insider ownership suggests inherent interests in company's expansion A total of 4 investors have a majority stake in the company with 50% o
Aipon Medical (300753.SZ): Pain products can be used in the nursing market to relieve patients' pain
Gelonghui, March 29丨Aipeng Medical (300753.SZ) said on the investor interactive platform that the company's pain products can all be used in the pension market to relieve patients' pain. The company's anesthesia depth monitor can be used to monitor the depth of anesthesia during surgery in elderly patients. The microcomputer injection pump can be used for accurate infusion and monitoring of traditional Chinese medicine solutions for clinical treatment such as post-operative analgesia, cancer pain analgesia, and tumor chemotherapy; internal heat needle therapy devices, shock wave therapy devices, etc. can all relieve chronic pain symptoms in elderly patients.
Aipeng Healthcare (300753.SZ): It accounts for a low share of Ruishenan shares and has not had an impact on the company's business
Gelonghui, March 20 | Aipeng Medical (300753.SZ) said on the investor interactive platform that the company participated in Changzhou Ruishenan Medical Devices Co., Ltd. in 2019, and the current shareholding ratio is 3.51%. Changzhou Ruishenan originated from the industry-university-research transformation of the Tsinghua University Microelectronics Institute team's implantable nerve stimulator project. The founding team graduated from Tsinghua University and was founded with the participation of Tsinghua Venture Capital and listed companies. According to data provided by Ruishenan, Ruishen's implantable closed-loop nerve stimulator system (CNS) can be used to treat various brain diseases such as Parkinson's disease, epilepsy, Alzheimer's disease, and depression. Currently
No Data